Simon Hirst
Gründer bei Sygnature Discovery Ltd.
Ursprung des Netzwerks ersten Grades von Simon Hirst
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Sygnature Discovery Ltd.
Sygnature Discovery Ltd. Pharmaceuticals: MajorHealth Technology Sygnature Discovery Ltd. engages in drug discovery activities. It specializes in target validation, hit identification, hit to lead, lead optimization, integrated drug discovery, and fragment based drug discovery. The company was founded by Simon Christopher Hirst in 2004 and is headquartered in Nottingham, United Kingdom.
8
| Holding Company | Pharmaceuticals: Major | 8 |
RenaSci Ltd.
RenaSci Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Aghoco (1579) Topco Ltd., RenaSci Ltd. provides pharmacy consulting services. The company is based in Nottingham, UK. The British company was founded in 2001 by Sharon Crawford Cheetham, Robert Brian Jones, David John Heal.
6
| Subsidiary | Miscellaneous Commercial Services | 6 |
Aghoco (1579) Topco Ltd.
Aghoco (1579) Topco Ltd. BiotechnologyHealth Technology Aghoco (1579) Topco Ltd. is a British biotechnology company founded in 2017. The private company is based in Nottingham, UK. and has subsidiaries in United Kingdom. Aghoco engages in research and development in biotechnology.
6
| Private Company | Biotechnology | 6 |
Aghoco 1578 (Midco) Ltd.
Aghoco 1578 (Midco) Ltd. Pharmaceuticals: MajorHealth Technology Part of Aghoco (1579) Topco Ltd., Aghoco 1578 (Midco) Ltd. operates as a holding British company whose subsidiary manufactures drugs. The company is based in Nottingham, UK and was founded in 2017.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Aghoco 1566 (Bidco) Ltd.
Aghoco 1566 (Bidco) Ltd. Financial ConglomeratesFinance Part of Aghoco (1579) Topco Ltd., Aghoco 1566 (Bidco) Ltd. functions as an investment holding British company. The company is based in Nottingham, UK.
5
| Subsidiary | Financial Conglomerates | 5 |
Evergreen Holdco 1 Ltd.
Evergreen Holdco 1 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Aghoco (1579) Topco Ltd., Evergreen Holdco 1 Ltd. operates as a holding British company with subsidiaries that engage in research and experimental development on biotechnology. The company is based in Nottingham, UK.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Sygil Group Ltd.
Sygil Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Evergreen Holdco 2 Ltd., Sygil Group Ltd. is a holding British company that provides drug discovery services. The company is based in Nottingham, UK and was founded in 2011.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Simon Hirst
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
Warwick Business School | College/University | Masters Business Admin | |
Aptuit LLC
Aptuit LLC Miscellaneous Commercial ServicesCommercial Services Aptuit LLC engages in the development of pharmaceutical and biotechnological products. Its offerings include drug design and discovery, preclinical biosciences, API development and manufacture, solid state chemistry, solid and oral dosage form development and manufacture, integrated drug discovery and drug development, Aptuit INDiGO, and physical and analytical chemistry services. The company was founded in December 2004 and is headquartered in Greenwich, CT. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal | |
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | Director/Board Member | |
Phoenix Equity Partners Ltd.
Phoenix Equity Partners Ltd. Investment ManagersFinance Phoenix Equity Partners Ltd.(Phoenix Equity Partners) is a private equity firm founded in 1984. The firm is headquartered in London, UK. | Investment Managers | Private Equity Investor Private Equity Investor | |
Beerse Betonhandel
Beerse Betonhandel Regional BanksFinance Part of Douterloigne Betonwerken, Beerse Betonhandel is a Belgian company that has a description related to depository banking functions not classified elsewhere. Beerse Betonhandel was acquired by Douterloigne Betonwerken on February 01, 1999. | Regional Banks | Corporate Officer/Principal | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Technical University of Denmark | College/University | Doctorate Degree | |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
ADEMTECH SA
ADEMTECH SA Miscellaneous Commercial ServicesCommercial Services ADEMTECH SA specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications. The firm produces magnetic nanoparticles for concentration, separation, purification, microfluidic device integration and identification of molecules and specific cells. The company was founded in 2000 and is headquartered in Pessac, France. | Miscellaneous Commercial Services | Director/Board Member | |
University of Geneva | College/University | Doctorate Degree | |
Universidad de Buenos Aires | College/University | Doctorate Degree | |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal | |
Institut National des Sciences Appliquées de Toulouse | College/University | Undergraduate Degree | |
The National Institute For Medical Research | College/University | Doctorate Degree | |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Kurma Partners SA
Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
Fondation Bettencourt Schueller | Investment Trusts/Mutual Funds | Director/Board Member | |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
École normale supérieure Paris-Saclay | College/University | Undergraduate Degree | |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Medical Specialties | Director/Board Member | |
The Innovative Medicines Initiative
The Innovative Medicines Initiative Drugstore ChainsRetail Trade The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles. | Drugstore Chains | Director/Board Member | |
Eclosion2 SA
Eclosion2 SA Financial ConglomeratesFinance Eclosion2 SA provides financial services. | Financial Conglomerates | Corporate Officer/Principal | |
PUMA BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
Lyonbiopôle
Lyonbiopôle Miscellaneous Commercial ServicesCommercial Services Lyonbiopôle is a competitiveness cluster located in Lyon, France. The French company serves as a catalyst for the health innovation ecosystem by connecting, developing, and promoting it. Lyonbiopôle's main focus is on the health sector, and it works to ensure that the ecosystem is thriving and innovative. | Miscellaneous Commercial Services | Director/Board Member | |
SAFE ORTHOPAEDICS SA | Medical Specialties | Director/Board Member | |
Asceneuron SA
Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
OBSEVA SA | Pharmaceuticals: Major | Director/Board Member | |
IGNYTA INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
Just Childcare Ltd.
Just Childcare Ltd. Other Consumer ServicesConsumer Services Just Childcare Ltd. provides child day care services. The firm offers outdoor play areas for children, homemade meals prepared with fresh ingredients, learning activities based on children’s individual needs and interests, and free early education entitlement. The company was founded by Jacqueline Ann Johnson and David William Johnson in 2004 and is headquartered in Manchester, the United Kingdom. | Other Consumer Services | Director/Board Member | |
GENEURO SA | Biotechnology | Director/Board Member | |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Founder | |
Eclosion2 & Cie Scpc | Corporate Officer/Principal | ||
Hoffmann-La Roche Products Ltd.
Hoffmann-La Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Hoffmann-La Roche Products Ltd. develops and manufactures pharmaceuticals and diagnostic solutions. The company is based in Hamilton, Bermuda. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Vonderscher & Co. Gmbh | Chief Executive Officer | ||
Vivet Therapeutics SAS
Vivet Therapeutics SAS BiotechnologyHealth Technology Vivet Therapeutics SAS develops novel gene therapy treatments for inherited metabolic diseases. The firm offers its services under the categorizers of Biopharma, Biotechnology and Health Care. The company was founded by Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza and Jens Kurth on July 26, 2016 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
DARÉ BIOSCIENCE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Just Childcare Holdings Ltd.
Just Childcare Holdings Ltd. Other Consumer ServicesConsumer Services Just Childcare Holdings Ltd. engages in provision of private day nurses. The company was founded on October 29, 2014 and is headquartered in Denton, the United Kingdom. | Other Consumer Services | Director/Board Member | |
Just Childcare Consultancy Services Ltd.
Just Childcare Consultancy Services Ltd. Financial ConglomeratesFinance Part of Just Childcare Holdings Ltd., Just Childcare Consultancy Services Ltd. functions as an investment holding British company. The company is based in Manchester, UK and was founded in 2014. | Financial Conglomerates | Director/Board Member | |
Corlieve Therapeutics SAS
Corlieve Therapeutics SAS Pharmaceuticals: MajorHealth Technology Corlieve Therapeutics SAS provides neurology services. The company was founded by Richard Porter, Valerie Crepel and Christophe Mulle in November 2019 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
IO BIOTECH, INC. | Biotechnology | Director/Board Member | |
ArisGen SA
ArisGen SA Pharmaceuticals: MajorHealth Technology ArisGen SA manufactures novel products. The private company is based in Plan-les-Ouates, Switzerland. The CEO of the Swiss company is Andrew Parker. | Pharmaceuticals: Major | Chief Executive Officer |
Statistik
International
Frankreich | 14 |
Vereinigtes Königreich | 10 |
Vereinigte Staaten | 10 |
Schweiz | 10 |
Belgien | 4 |
Sektoral
Health Technology | 25 |
Consumer Services | 10 |
Finance | 7 |
Commercial Services | 4 |
Miscellaneous | 3 |
Operativ
Director/Board Member | 98 |
Corporate Officer/Principal | 30 |
Founder | 10 |
Chief Executive Officer | 9 |
Independent Dir/Board Member | 8 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Simon Hirst
- Unternehmensverbindungen